For research use only. Not for therapeutic Use.
GST-HG131（Cat No.:I042660）is a recombinant fusion protein that combines glutathione S-transferase (GST) with HG131, a targeted therapeutic peptide. This fusion allows for the efficient purification and delivery of HG131, which is designed to inhibit specific protein-protein interactions involved in cancer cell proliferation and metastasis. GST-HG131 has shown promise in preclinical studies for its potential to treat cancers by disrupting pathways crucial for tumor growth and spread. Researchers are exploring its applications in targeted cancer therapies, particularly in tumors that are resistant to conventional treatments, with an emphasis on improving drug delivery and efficacy.
| CAS Number | 2270215-69-3 |
| Synonyms | (7R)-7-tert-butyl-2-methoxy-3-(3-methoxypropoxy)-11-oxo-6,7-dihydropyrido[1,2-d][1,4]benzoxazepine-10-carboxylic acid |
| Molecular Formula | C23H29NO7 |
| Purity | ≥95% |
| IUPAC Name | (7R)-7-tert-butyl-2-methoxy-3-(3-methoxypropoxy)-11-oxo-6,7-dihydropyrido[1,2-d][1,4]benzoxazepine-10-carboxylic acid |
| InChI | InChI=1S/C23H29NO7/c1-23(2,3)21-13-31-18-11-20(30-8-6-7-28-4)19(29-5)9-14(18)16-10-17(25)15(22(26)27)12-24(16)21/h9-12,21H,6-8,13H2,1-5H3,(H,26,27)/t21-/m0/s1 |
| InChIKey | PQMAMDUBYCMNAT-NRFANRHFSA-N |
| SMILES | CC(C)(C)[C@@H]1COC2=CC(=C(C=C2C3=CC(=O)C(=CN13)C(=O)O)OC)OCCCOC |
